This article is more than 5 years old. Information may no longer be current.

Fox Chase Cancer Center appoints head of medical oncology

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Deric Savior, MD, has been promoted to head of medical oncology at Fox Chase Cancer Center at Temple University Hospital.

Savior — who specializes in treating lung cancers and head and neck cancers — will lead efforts to expand medical oncology services. His priorities will include strengthening cancer research efforts, including increasing clinical trial enrollment.

Savior joined the medical oncology faculty at Temple in 2009. He previously led the Fox Chase thoracic oncology section at Temple University Hospital.

“Over nearly a decade on the Temple faculty, Deric has served in a number of important roles, and I am excited to see all that his leadership will bring to our collaborative hematology/oncology section,” Martin J. Edelman, MD, chair of the department of hematology/oncology at Fox Chase, said in a press release. “He has been instrumental in meeting our goal to provide the same world-class clinical care and access to the latest trials to our patients at both locations.”